HYFT

MindWalk Holdings Corp.

41
Fundamentals40/ 100
Valuation50/ 100
Upside potential64/ 100
Risk potential44/ 100

HYFT trails on the overall score without a compensating advantage in the available component scores.

LLY

Eli Lilly and Company

78
Fundamentals85/ 100
Valuation62/ 100
Upside potential72/ 100
Risk potential15/ 100

LLY has the edge over HYFT overall, supported by stronger fundamentals and lower modeled downside.

HYFT Fundamentals

MetricStatus
Under pressure
Weak
Weak
Strong

HYFT's balance sheet is currently strong, but its revenue, profitability and cash flow are under pressure.

LLY Fundamentals

MetricStatus
Healthy
Strong
Strong
Healthy

LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.

HYFT PE Valuation

HYFT has no meaningful PE right now: it lost money over the past year.

LLY PE Valuation

CHEAPFAIREXPENSIVE37x74x111x147x
CHEAPFAIREXPENSIVE37x74x111x147x
LevelPEPriceVs current
Cheap27x$845-41%
Forward30x$1,427—
Current46x$1,427—
Fair48x$1,466+2.7%
Expensive85x$2,612+83%

Historical ranges are pointers, not guarantees.

LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.

HYFT Forward outlook

MetricOutlook
--
Losses growing
Growth
Strongly weakening
Limited
Moderate

Analysts expect HYFT's losses to grow, with revenue growing.

LLY Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Moderate

LLY has the edge over HYFT on the outlook, with more favorable earnings and profitability expectations.

HYFT Risk to reward

ScenarioChangePrice
Upside+80%$1.80
Downside-44%$0.56

Calculated from the latest close: $1.00 on Nov 12.

HYFT trails LLY on modeled risk to reward, with less potential upside relative to its potential downside.

LLY Risk to reward

ScenarioChangePrice
Upside+39%$1,988.49
Downside-15%$1,209.08

Calculated from the latest close: $1,427.28 on Nov 12.

LLY has a better modeled risk to reward balance than HYFT, with more potential upside relative to its potential downside.

HYFT Earnings Per Share

Q4 2023: $-0.44Q1 2024: $-0.39Q2 2026: $-0.21Q3 2026: $-0.26
Q4 2023: $-0.44Q1 2024: $-0.39Q2 2026: $-0.21Q3 2026: $-0.26
QuarterTTM EPSYoY
Q3 2022-$0.75-$0.34
Q2 2022-$0.60-$0.29
Q1 2022-$0.65-$0.50
Q4 2021-$0.57-$0.44
Q3 2021-$0.41-$0.23
Q2 2021-$0.31-$0.05
Q1 2021-$0.15+$0.26
Q4 2020-$0.13+$0.31

LLY has the stronger earnings trend. Trailing diluted EPS is down 135% for HYFT versus LLY up 51%.

LLY Earnings Per Share

Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
Q4 2023: $5.80Q1 2024: $6.79Q2 2024: $8.12Q3 2024: $9.25Q4 2024: $11.71Q1 2025: $12.29Q2 2025: $15.30Q3 2025: $20.44Q4 2025: $22.95Q1 2026: $28.15Q2 2026: $29.80Q3 2026: $30.81Forward: $46.82
QuarterTTM EPSYoY
Forward$46.82+52%
Q3 2026$30.81+51%
Q2 2026$29.80+95%
Q1 2026$28.15+129%
Q4 2025$22.95+96%
Q3 2025$20.44+121%
Q2 2025$15.30+88%
Q1 2025$12.29+81%
Q4 2024$11.71+102%

LLY's earnings per share have climbed steadily: $30.81 over the past year, up 51% from the year before, and higher year over year for 11 quarters in a row.

HYFT Quarterly Revenue

Q4 2023: $4MQ1 2024: $4MQ2 2024: $5MQ3 2024: $4MQ4 2024: $4MQ1 2025: $4MQ2 2025: $5MQ3 2025: $2MQ4 2025: $3MQ1 2026: $3MQ2 2026: $3MQ3 2026: $3M
Q4 2023: $4MQ1 2024: $4MQ2 2024: $5MQ3 2024: $4MQ4 2024: $4MQ1 2025: $4MQ2 2025: $5MQ3 2025: $2MQ4 2025: $3MQ1 2026: $3MQ2 2026: $3MQ3 2026: $3M
QuarterRevenueYoY
Q3 2026$2.7M+23%
Q2 2026$2.9M-42%
Q1 2026$2.9M-32%
Q4 2025$2.9M-33%
Q3 2025$2.2M-40%
Q2 2025$4.9M+8.1%
Q1 2025$4.3M-1.1%
Q4 2024$4.3M-0.4%

HYFT's revenue is recovering but still below its 2025 peak: $3M last quarter, up 23% from the same quarter a year ago.

LLY Quarterly Revenue

Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
Q4 2023: $9.4BQ1 2024: $8.8BQ2 2024: $11.3BQ3 2024: $11.4BQ4 2024: $13.5BQ1 2025: $12.7BQ2 2025: $15.6BQ3 2025: $17.6BQ4 2025: $19.3BQ1 2026: $19.8BQ2 2026: $23BQ3 2026: $24.4B
QuarterRevenueYoY
Q3 2026$24.4B+39%
Q2 2026$23B+48%
Q1 2026$19.8B+56%
Q4 2025$19.3B+43%
Q3 2025$17.6B+54%
Q2 2025$15.6B+38%
Q1 2025$12.7B+45%
Q4 2024$13.5B+45%

LLY has the edge over HYFT on sales, with more consistent year-over-year improvement.

HYFT Free Cash Flow

Q4 2023: −$222,863Q1 2024: −$352,222Q2 2024: −$3MQ3 2024: −$1MQ4 2024: −$2MQ1 2025: −$924,494Q2 2025: −$1MQ3 2025: −$3MQ4 2025: −$2MQ1 2026: −$2MQ2 2026: −$2MQ3 2026: −$3M
Q4 2023: −$222,863Q1 2024: −$352,222Q2 2024: −$3MQ3 2024: −$1MQ4 2024: −$2MQ1 2025: −$924,494Q2 2025: −$1MQ3 2025: −$3MQ4 2025: −$2MQ1 2026: −$2MQ2 2026: −$2MQ3 2026: −$3M
QuarterFree cash flowYoY
Q3 2026-$2.9M+$218.3K
Q2 2026-$1.8M-$719.4K
Q1 2026-$2.1M-$1.2M
Q4 2025-$2.1M-$447.1K
Q3 2025-$3.2M-$1.7M
Q2 2025-$1.1M+$1.6M
Q1 2025-$924.5K-$572.3K
Q4 2024-$1.6M-$1.4M

HYFT has burned cash in almost every quarter: −$9M over the past year, against −$7M the year before.

LLY Free Cash Flow

Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
Q4 2023: −$1.4BQ1 2024: $180MQ2 2024: $241MQ3 2024: $2.4BQ4 2024: $978MQ1 2025: $156MQ2 2025: $1.4BQ3 2025: $6.7BQ4 2025: $678MQ1 2026: $3BQ2 2026: $7.8BQ3 2026: $8.2B
QuarterFree cash flowYoY
Q3 2026$8.2B+22%
Q2 2026$7.8B+458%
Q1 2026$3B+1826%
Q4 2025$677.9M-31%
Q3 2025$6.7B+186%
Q2 2025$1.4B+476%
Q1 2025$156.1M-13%
Q4 2024$977.8M+$2.4B

LLY has the edge over HYFT on cash generation, producing positive trailing cash flow while its opponent burns cash.

HYFT Total Shares

Q4 2023: 25MQ1 2024: 26MQ2 2024: 26MQ3 2024: 27MQ4 2024: 28MQ1 2025: 33MQ3 2025: 46MQ4 2025: 46MQ1 2026: 47MQ2 2026: 47MQ3 2026: 47M
Q4 2023: 25MQ1 2024: 26MQ2 2024: 26MQ3 2024: 27MQ4 2024: 28MQ1 2025: 33MQ3 2025: 46MQ4 2025: 46MQ1 2026: 47MQ2 2026: 47MQ3 2026: 47M
PeriodChange %Net change
Quarterly+0.2%+95.2K shares
1 year+1.4%+653K shares
3 years+87%+21.8M shares
5 years+177%+29.9M shares
Available history+244%+33.2M shares

HYFT has 47M diluted shares, up 1.4% from a year ago.

LLY Total Shares

Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
Q4 2023: 903MQ1 2024: 904MQ2 2024: 904MQ3 2024: 905MQ4 2024: 904MQ1 2025: 901MQ2 2025: 900MQ3 2025: 899MQ4 2025: 899MQ1 2026: 896MQ2 2026: 894MQ3 2026: 893M
PeriodChange %Net change
Quarterly0%-300K shares
1 year-0.6%-5.4M shares
3 years-0.7%-6.4M shares
5 years-1.9%-17.4M shares
Available history-4.5%-42.3M shares

LLY has the edge over HYFT on shareholder dilution, with a more favorable share count trend.

HYFT Net Leverage

QuarterNet LeverageStatus
Q1 2021-7.4xNet Cash
Q4 2020-5.5xNet Cash
Q3 2020-0.8xNet Cash

HYFT has more cash than debt.

LLY Net Leverage

Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
Q4 2023: 2.8xQ1 2024: 2.6xQ2 2024: 2.4xQ3 2024: 2.4xQ4 2024: 2.1xQ1 2025: 2.3xQ2 2025: 2.0xQ3 2025: 1.3xQ4 2025: 1.3xQ1 2026: 1.2xQ2 2026: 1.3xQ3 2026: 1.2x
QuarterNet LeverageStatus
Q3 20261.2xHealthy
Q2 20261.3xHealthy
Q1 20261.2xHealthy
Q4 20251.3xHealthy
Q3 20251.3xHealthy
Q2 20252.0xHealthy
Q1 20252.3xModerate
Q4 20242.1xModerate

LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.

HYFT Weekly Momentum

MetricValueStatus
RSI35.9Neutral
Stochastic8.2Oversold

HYFT's weekly RSI is 36 (neutral) and its Stochastic is 8 (oversold).

LLY Weekly Momentum

MetricValueStatus
RSI68.3Neutral
Stochastic84.1Overbought

LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).

HYFT PE vs Healthcare Sector

HYFT has no meaningful PE right now: it lost money over the past year.

LLY PE vs Healthcare Sector

MetricLLYSector medianRelative
PE46x26x79% above
PE %482919 pts above

LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.

HYFT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1.2319% below
20 week MA$1.3224% below
50 week MA$1.4531% below
100 week MA$1.2822% below
200 week MA$1.5636% below

HYFT is in a downtrend: it's below all five of its weekly moving averages, and 36% below its 200-week average.

LLY Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$1,279.412% above
20 week MA$1,218.817% above
50 week MA$1,102.229% above
100 week MA$954.150% above
200 week MA$797.579% above

LLY has the edge over HYFT on trend strength, trading above more of its moving averages.

HYFT Yearly ROI

YearStart priceEnd priceROI
2020$2.20$16.4+645%
2021$16.4$5.36-67%
2022$5.36$5.72+6.7%
2023$5.72$1.71-70%
2024$1.71$0.41-76%
2025$0.41$1.70+315%
2026 YTD$1.70$1.00-41%

HYFT's yearly returns have swung widely, from +645% in 2020 to −76% in 2024. It's down 41% so far in 2026.

LLY Yearly ROI

YearStart priceEnd priceROI
2020$131.5$166.7+27%
2021$166.7$273.1+64%
2022$273.1$367.9+35%
2023$367.9$582.9+58%
2024$582.9$783.2+34%
2025$783.2$1,077.8+38%
2026 YTD$1,077.8$1,427.3+32%

LLY has the edge over HYFT on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key